20 July - 15.00-16.00 BST
Globalization has opened new markets to the pharmaceutical industry, but it has also added more complexities. Each jurisdiction has its own regulations and government policies, market access requirements, local and regional expectations as well as rapidly growing consumer demands.
Companies must factor all these issues in when considering developing, manufacturing, marketing, distribution, reimbursement and maintenance of medicinal products. As a result, they must plan strategically before launching their products and ensure they understand cost constraints, the patient population and medical need in each market and issues such as potential supply chain obstacles.
This webinar will explore efforts by regulatory authorities to improve collaborative efforts in order to streamline the development and approval process, to deploy resources efficiently and important considerations to help companies reach desired markets in a time- and cost-efficient manner.
• Understanding and planning for key market dynamics at a global, regional and local level to help bring new medicinal products to market and expand into new territories
• Strategic decision-making when selecting the right first market/s in which to seek marketing authorization
• Taking advantage of some collaborative/convergence efforts with regulators vs managing a patchwork of national guidelines
Dr. Jürgen Hönig, Senior Director, Regulatory Business Intelligence
This webinar is sponsored by Pharmalex.
Disclaimer: Whilst TOPRA is running this webinar for Pharmalex, this is not an endorsement of Pharmalex, Pharmalex's affiliates, employees or its products and services. TOPRA is also not responsible for the content or views expressed during the webinar.
How do I register?
Simply log in or create an account and register below.
- Members: free
- Non-members: free
Terms and Conditions
By purchasing this webinar, you are agreeing to TOPRA's training terms and conditions.